abstract |
The present invention provides compositions and methods for reversibly inhibiting S-adenosyl-L-homocysteine (SAH) hydrolase. The compounds of the present invention can be used in combination with anti-hemorrhagic virus infection agents, immunosuppressive agents, homocysteine-lowering agents, or anti-neoplastic agents. The compositions and methods of the present invention may be used to prevent and treat hemorrhagic viral infections, autoimmune diseases, autograft rejection, neoplasms, hyperhomocysteine failure, cardiovascular disease, stroke, Alzheimer's disease, or diabetes. Can be used. [Selection] Figure 10 |